291 related articles for article (PubMed ID: 6275404)
1. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
[TBL] [Abstract][Full Text] [Related]
2. Contraception with LHRH agonists, a new physiological approach.
Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
[TBL] [Abstract][Full Text] [Related]
3. Luteinizing hormone releasing hormone analogues for contraception.
Nillius SJ
Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
[TBL] [Abstract][Full Text] [Related]
4. Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum.
Séguin C; Bélanger A; Labrie F; Hansel W
Endocrinology; 1982 Feb; 110(2):524-30. PubMed ID: 6276140
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
6. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
[TBL] [Abstract][Full Text] [Related]
7. Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.
Labrie F; Cusan L; Séguin C; Bélanger A; Pelletier G; Reeves J; Kelly PA; Lemay A; Raynaud JP
Int J Fertil; 1980; 25(3):157-70. PubMed ID: 6108924
[No Abstract] [Full Text] [Related]
8. Reproductive pharmacology of LHRH and agonists in females and males.
Corbin A; Bex FJ
Acta Eur Fertil; 1980 Jun; 11(2):113-30. PubMed ID: 7010866
[TBL] [Abstract][Full Text] [Related]
9. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
Lemay A; Faure N; Labrie F; Fazekas AT
Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
[TBL] [Abstract][Full Text] [Related]
10. Antifertility effects of an LH-RH analogue in male rats and dogs.
Sandow J; von Rechenberg W; Baeder C; Engelbart K
Int J Fertil; 1980; 25(3):213-21. PubMed ID: 6108932
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.
Cusan L; Auclair C; Belanger A; Ferland L; Kelly PA; Seguin C; Labrie F
Endocrinology; 1979 May; 104(5):1369-76. PubMed ID: 220032
[TBL] [Abstract][Full Text] [Related]
12. Sites of paradoxical action of the LHRH agonist (D-Trp6)-LHRH.
Arimura A; Talbot S; Serafini PC; Schally AV
Int J Fertil; 1980; 25(3):151-6. PubMed ID: 6108923
[TBL] [Abstract][Full Text] [Related]
13. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
14. The different mechanisms for suppression of pituitary and testicular function.
Sandow J; Engelbart K; von Rechenberg W
Med Biol; 1986; 63(5-6):192-200. PubMed ID: 3010006
[TBL] [Abstract][Full Text] [Related]
15. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
[TBL] [Abstract][Full Text] [Related]
16. The search for male contraception. Men are different.
Steinmann M
RF Illus; 1982 Jun; ():29-31. PubMed ID: 12264477
[TBL] [Abstract][Full Text] [Related]
17. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
Dirami G; Cooke BA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
[TBL] [Abstract][Full Text] [Related]
18. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
[TBL] [Abstract][Full Text] [Related]
20. Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.
Wang NG; Sundaram K; Pavlou S; Rivier J; Vale W; Bardin CW
Endocrinology; 1983 Jan; 112(1):331-5. PubMed ID: 6291919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
